Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment.
Ascites
Extracellular matrix
Immunotherapy
Ovarian cancer
Tumor microenvironment
Journal
Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
15
12
2021
revised:
11
03
2022
accepted:
30
03
2022
pubmed:
9
4
2022
medline:
23
11
2022
entrez:
8
4
2022
Statut:
ppublish
Résumé
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the field of cancer, the majority of patients with ovarian cancer are still being diagnosed at an advanced stage of the disease due to lack of effective screening tools. The overall survival of these patients has, therefore, not substantially improved over the past decades. Most patients undergo debulking surgery and treatment with chemotherapy, but often micrometastases remain and acquire resistance to the therapy, eventually leading to disease recurrence. Here, we summarize the current knowledge in epithelial ovarian cancer development and metastatic progression. For the most common subtypes, we focus further on the properties and functions of the immunosuppressive tumor microenvironment, including the extracellular matrix. Current and future treatment modalities are discussed and finally we provide an overview of the different experimental models used to develop novel therapies.
Identifiants
pubmed: 35395389
pii: S1044-579X(22)00083-9
doi: 10.1016/j.semcancer.2022.03.027
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
207-223Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest Nothing to declare.